Qiumeng Liu

952 total citations
33 papers, 616 citations indexed

About

Qiumeng Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qiumeng Liu has authored 33 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Qiumeng Liu's work include RNA modifications and cancer (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Ubiquitin and proteasome pathways (4 papers). Qiumeng Liu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Ubiquitin and proteasome pathways (4 papers). Qiumeng Liu collaborates with scholars based in China, United States and Saudi Arabia. Qiumeng Liu's co-authors include Bixiang Zhang, Huifang Liang, Xiaoping Chen, Liang Chu, Jin Chen, Jia Song, Zeyang Ding, Chengpeng Yu, Long Zhang and Chaoyi Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Oncogene.

In The Last Decade

Qiumeng Liu

31 papers receiving 613 citations

Peers

Qiumeng Liu
Danyu Du China
Yu Geng China
Feihu Bai China
Ming Lv China
Chuanyong Zhang China
Qi Huang China
Fengli Hu China
Laura Antonucci Italy
Pengpeng Liu China
Danyu Du China
Qiumeng Liu
Citations per year, relative to Qiumeng Liu Qiumeng Liu (= 1×) peers Danyu Du

Countries citing papers authored by Qiumeng Liu

Since Specialization
Citations

This map shows the geographic impact of Qiumeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiumeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiumeng Liu more than expected).

Fields of papers citing papers by Qiumeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiumeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiumeng Liu. The network helps show where Qiumeng Liu may publish in the future.

Co-authorship network of co-authors of Qiumeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiumeng Liu. A scholar is included among the top collaborators of Qiumeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiumeng Liu. Qiumeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mo, Jie, Su Chen, Qiumeng Liu, et al.. (2025). Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma. Cell Death and Disease. 16(1). 797–797.
2.
Wang, Tianci, Ran Tao, Qiumeng Liu, et al.. (2025). TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway. Journal of Hepatology. 83(1). 105–118. 4 indexed citations
3.
4.
Mo, Jie, Su Chen, Pengcheng Li, et al.. (2024). CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression. Autophagy. 21(4). 840–859. 3 indexed citations
5.
Xu, Lei, Qiumeng Liu, Hui Li, et al.. (2024). Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation. Cancer Communications. 44(9). 1018–1041. 20 indexed citations
6.
Wen, Jingyuan, Xue Lin, Wei Yi, et al.. (2024). YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis. Advanced Science. 11(13). e2307242–e2307242. 39 indexed citations
7.
Wei, Yi, Tuying Yong, Wenlong Jia, et al.. (2023). Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p. Advanced Science. 10(17). e2207080–e2207080. 19 indexed citations
8.
Zhang, Man, Zhong Li, Kaixuan Feng, et al.. (2023). Strategies for indica rice adapted to high-temperature stress in the middle and lower reaches of the Yangtze River. Frontiers in Plant Science. 13. 1081807–1081807. 8 indexed citations
9.
Qiao, Cece, et al.. (2023). Effects of Biological Nitrification Inhibitor on Nitrous Oxide and nosZ, nirK, nirS Denitrifying Bacteria in Paddy Soils. Sustainability. 15(6). 5348–5348. 10 indexed citations
10.
Chen, Jin, Qiumeng Liu, Jie Mo, et al.. (2023). USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma. Oncogene. 43(2). 123–135. 12 indexed citations
11.
Yang, Zhenhua, Qiumeng Liu, Lei Xu, et al.. (2023). The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease. International Journal of Biological Sciences. 20(1). 113–126. 23 indexed citations
12.
Pan, Yonglong, Mengzhen Han, Xiaochao Zhang, et al.. (2022). Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway. Cellular Oncology. 45(1). 163–178. 27 indexed citations
13.
Chen, Jin, Hanhua Dong, Qiumeng Liu, et al.. (2022). MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma. Oncogene. 42(3). 169–183. 13 indexed citations
14.
Zhang, Xiaochao, Yonglong Pan, Yixiao Xiong, et al.. (2022). DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6. Oncogene. 41(12). 1821–1834. 32 indexed citations
15.
Song, Jia, Yachong Liu, Furong Liu, et al.. (2020). The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway. Theranostics. 11(3). 996–1015. 63 indexed citations
16.
Song, Jia, Xiaochao Zhang, Zhibin Liao, et al.. (2019). 14–3-3ζ inhibits heme oxygenase-1 (HO-1) degradation and promotes hepatocellular carcinoma proliferation: involvement of STAT3 signaling. Journal of Experimental & Clinical Cancer Research. 38(1). 3–3. 20 indexed citations
17.
Zhang, Long, Jin Chen, Qiumeng Liu, et al.. (2019). FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21. Journal of Experimental & Clinical Cancer Research. 38(1). 101–101. 75 indexed citations
18.
Chen, Jin, Qiumeng Liu, Long Zhang, et al.. (2019). DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 273–273. 22 indexed citations
19.
Chen, Jin, Jia Song, Qiumeng Liu, et al.. (2018). 18β-Glycyrrhetinic-acid-mediated unfolded protein response induces autophagy and apoptosis in hepatocellular carcinoma. Scientific Reports. 8(1). 9365–9365. 32 indexed citations
20.
Song, Jia, Xiaochao Zhang, Chaoyi Yuan, et al.. (2018). CRISPR/Cas9‐mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV‐positive hepatocellular carcinoma cells. Journal of Cellular Biochemistry. 119(10). 8419–8431. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danyu Du Breakdown of academic impact, for papers by Yu Geng Breakdown of academic impact, for papers by Feihu Bai Breakdown of academic impact, for papers by Ming Lv Breakdown of academic impact, for papers by Chuanyong Zhang Breakdown of academic impact, for papers by Qi Huang Breakdown of academic impact, for papers by Fengli Hu Breakdown of academic impact, for papers by Laura Antonucci Breakdown of academic impact, for papers by Pengpeng Liu
Rankless by CCL
2026